Randomized Trialhigh evidence
Desmodium styracifolium Total Flavone Capsules for Urolithiasis: A Phase 3 Randomized Clinical Trial.
JAMA network open·September 1, 2026·PMID 42714908
Why it mattersNo oral medication is currently approved for urolithiasis, and medical expulsive therapy options are limited. This trial provides high-level evidence that a traditional Chinese herbal extract may improve stone passage for appropriately selected patients, potentially offering a new non-invasive treatment option.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled